Generics Organizations that do their own drug or API manufacturing recognise that the primary bottleneck in releasing a batch to market is the time and effort required to build the master batch record (MBR) after the processing steps have been completed. The goal for manufacturing divisions is to minimize the manual steps that slow down the process and also affect the accuracy and completeness of the information.
By utilizing the automated QUMAS Electronic Batch Record solution manufacturing divisions can benefit from:
- Reduced cycle time
- Reduced inventory
- Reduced data entry errors
- Improved visibility of production and process exceptions
- Rapid return on investment